ArticleInfectious agents and cancer2008
Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.
Article in Infectious agents and cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 26 citations in OpenAlex.
- Human Papillomavirus (HPV) Prevalence and Type Distribution in Urban Areas of Malaysia.Asian Pacific journal of cancer prevention : APJCP · 2021Article
- Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.Journal of clinical microbiology · 2018Article
- Integration of human papillomavirus type 16 in cervical cancer cells.Open medicine (Warsaw, Poland) · 2015Article
- Rome Consensus Conference - statement; human papilloma virus diseases in males.BMC public health · 2013Article
- Prevalence and distribution of human papillomavirus infection in Korean women as determined by restriction fragment mass polymorphism assay.Journal of Korean medical science · 2012Article
- Article
- Prevalence of human papillomavirus infection in women in Benin, West Africa.Virology journal · 2011Article
- Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.Future microbiology · 2011Review
- Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.Journal of clinical microbiology · 2011Article
- Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of Italy.Infectious diseases in obstetrics and gynecology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo provide guidelines for health-care providers on strategies for cervical cancer prevention based on HPV testing and anti-HPV vaccination. OUTCOMES: Overall efficacy of different preventive strategies, assessing reduction in the incidence of invasive cervical cancer and precancerous lesions. EVIDENCE: Medline and the Cochrane Database were searched for articles in English on subjects related to HPVs, HPV diagnosis, HPV anogenital lesions, cervical cancer, HPV testing, and HPV vaccines, in order to elaborate an up-dated document. Relevant Italian Government publications and position papers from appropriate health and family planning organizations were also reviewed. VALUES: The quality of the evidence and ranking of recommendations for practice were rated using criteria defined by SIV, which were adapted from the Canadian Task Force on Preventive Health Care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.